BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 500 shares, a drop of 83.3% from the March 31st total of 3,000 shares. Based on an average daily volume of 4,700 shares, the short-interest ratio is presently 0.1 days.

BioSyent Stock Performance

Shares of OTCMKTS:BIOYF remained flat at $6.28 on Friday. 20 shares of the stock traded hands, compared to its average volume of 2,903. BioSyent has a 12-month low of $5.26 and a 12-month high of $6.97. The stock’s 50-day moving average is $6.34 and its 200-day moving average is $6.28.

BioSyent Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 15th. Investors of record on Thursday, February 29th were given a dividend of $0.0332 per share. This is a boost from BioSyent’s previous dividend of $0.03. This represents a yield of 2.08%. The ex-dividend date of this dividend was Wednesday, February 28th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.